REVELATION BIOSC. DL-,001
REVELATION BIOSC. DL-,001
Share · US76135L5075 · REVB · A401N4 (XNCM)
Overview Financial Indicators
0,76 EUR
4,23 % 0,03 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 21:23

Current Prices from REVELATION BIOSC. DL-,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
REVB
USD
09.06.2025 21:23
0,87 USD
0,86 USD
+0,58 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
4,04 % -12,06 % -72,51 % -75,87 % -88,44 % -97,68 % -100,00 %

Company Profile for REVELATION BIOSC. DL-,001 Share

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.

Company Data

Name REVELATION BIOSC. DL-,001
Company Revelation Biosciences, Inc.
Symbol REVB
Website https://www.revbiosciences.com
Primary Exchange XNCM Frankfurt
WKN A401N4
ISIN US76135L5075
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. James M. Rolke
Country United States of America
Currency EUR
Employees 0,0 T
Address 4660 La Jolla Village Drive, 92122 San Diego
IPO Date 2020-11-17

Stock Splits

Date Split
28.01.2025 1:16

ID Changes

Date From To
11.01.2022 PAIC REVB

Ticker Symbols

Name Symbol
NASDAQ REVB

More Shares

Investors who REVELATION BIOSC. DL-,001 hold also have the following shares in their portfolio:
BurTech Acquisition Corp. - Warrants
BurTech Acquisition Corp. - Warrants Share
DEKA HPF MTN R.A162
DEKA HPF MTN R.A162 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025